Schedule 13G ownership disclosure
OXFORD IMMUNOTEC GLOBAL PL
Security class unavailable · CUSIP: G6855A103
Event date: 2020-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,470,593
- Percent of class
- 5.6600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-21-001291
- Form type
- SC 13G
- Filer
- Oxford Immunotec Global PLC
- CIK
- CIK 1586049
- Filed
- Feb 12, 2021
- Reporting period
- Dec 31, 2020
- Description
- Schedule 13G beneficial ownership